CA Stock MarketDetailed Quotes
MIR MedMira Inc
- 0.085
- 0.0000.00%
15min DelayTrading Dec 16 14:12 ET
59.65MMarket Cap-17.00P/E (TTM)
0.090High0.080Low245.50KVolume0.090Open0.085Pre Close21.22KTurnover0.11552wk High0.11%Turnover Ratio701.73MShares0.07052wk Low-0.005EPS TTM19.02MFloat Cap17.500Historical HighLossP/E (Static)223.80MShs Float0.005Historical Low-0.005EPS LYR11.77%Amplitude--Dividend TTM-3.27P/B1Lot Size--Div YieldTTM
MedMira Inc Key Stats
Quarterly+Annual
YOY
| (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | (Q1)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.61%412.57K | 83.07%64.46K | -23.08%81.55K | -12.81%148.7K | -2.41%117.86K | -54.57%432.53K | -72.61%35.21K | -67.27%106.01K | -42.67%170.54K | -40.26%120.77K |
| Operating revenue | -4.61%412.57K | 83.07%64.46K | -23.08%81.55K | -12.81%148.7K | -2.41%117.86K | -54.57%432.53K | -72.61%35.21K | -67.27%106.01K | -42.67%170.54K | -40.26%120.77K |
| Cost of revenue | 40.81%186.08K | 272.17%27.05K | -30.19%31.24K | -0.05%80.56K | 109.88%47.23K | -79.61%132.15K | -150.02%-15.71K | -80.31%44.75K | -61.96%80.6K | -87.32%22.5K |
| Gross profit | -24.60%226.49K | -26.53%37.41K | -17.88%50.31K | -24.24%68.14K | -28.12%70.63K | -1.20%300.38K | -47.58%50.92K | -36.59%61.26K | 5.08%89.94K | 297.95%98.27K |
| Operating expense | 27.80%2.66M | 81.36%897.98K | 23.87%653.4K | -5.10%436.29K | 12.17%668.73K | 32.09%2.08M | 27.99%495.13K | 34.40%527.49K | 3.27%459.75K | 70.81%596.15K |
| Selling and administrative expenses | 42.43%1.48M | 137.09%550.65K | -38.94%264.15K | 79.92%302.46K | 76.02%362.22K | 38.58%1.04M | 17.10%232.26K | 152.54%432.59K | -27.76%168.11K | 39.75%205.78K |
| -Selling and marketing expense | 44.37%283.13K | 2,215.10%65.8K | -65.37%61.42K | 1,707.19%85.48K | 530.44%70.43K | 1,230.29%196.11K | -74.16%2.84K | 4,946.06%177.37K | 1,550.92%4.73K | 1,909.17%11.17K |
| -General and administrative expense | 41.98%1.2M | 111.35%484.86K | -20.57%202.73K | 32.81%216.98K | 49.94%291.79K | 14.67%842.61K | 22.45%229.41K | 52.11%255.22K | -29.89%163.38K | 32.67%194.61K |
| Research and development costs | 1.32%476.89K | 34.70%105.9K | 100.59%194.15K | -28.21%76.36K | -46.81%100.49K | 146.25%470.68K | -34.76%78.62K | 166.50%96.79K | 900.35%106.36K | 296.84%188.92K |
| Other operating expenses | 23.00%700.03K | 31.03%241.43K | 10,461.13%195.1K | -68.98%57.47K | 2.26%206.03K | -10.07%569.11K | 170.92%184.25K | -101.02%-1.88K | -17.94%185.28K | 30.67%201.46K |
| Operating profit | -36.65%-2.43M | -93.73%-860.57K | -29.35%-603.09K | 0.45%-368.15K | -20.13%-598.1K | -40.06%-1.78M | -53.33%-444.21K | -57.57%-466.23K | -2.84%-369.81K | -53.51%-497.89K |
| Net non-operating interest income (expenses) | 0.12%-896.41K | 39.35%-314.46K | -43.08%-177.05K | -84.46%-222.64K | -35.45%-182.26K | -59.69%-897.52K | -198.94%-518.51K | -7.44%-123.75K | -11.01%-120.7K | 18.29%-134.56K |
| Non-operating interest expense | -0.35%882.41K | -40.68%300.46K | 43.08%177.05K | 84.46%222.64K | 35.45%182.26K | 60.41%885.52K | 209.89%506.51K | 7.44%123.75K | 11.01%120.7K | -18.29%134.56K |
| Total other finance cost | 16.67%14K | ---- | ---- | ---- | ---- | 20.00%12K | ---- | ---- | ---- | ---- |
| Other net income (expenses) | ||||||||||
| Income before tax | -24.32%-3.33M | -22.05%-1.18M | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -24.32%-3.33M | -22.05%-1.18M | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K |
| Net income continuous operations | -24.32%-3.33M | -22.05%-1.18M | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -24.32%-3.33M | -22.05%-1.18M | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -24.32%-3.33M | -22.05%-1.18M | -32.23%-780.15K | -20.44%-590.79K | -23.39%-780.36K | -46.09%-2.68M | -107.86%-962.72K | -43.52%-589.98K | -4.73%-490.51K | -29.33%-632.45K |
| Diluted earnings per share | -25.00%-0.005 | 0.00%-0.002 | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | -33.33%-0.004 | -100.00%-0.002 | -66.67%-0.001 | -42.86%-0.001 | 0.00%-0.001 |
| Basic earnings per share | -25.00%-0.005 | 0.00%-0.002 | 0.00%-0.001 | 0.00%-0.001 | 0.00%-0.001 | -33.33%-0.004 | -100.00%-0.002 | -66.67%-0.001 | -42.86%-0.001 | 0.00%-0.001 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data